Broncus Holding Corporation (2216.HK)

HKSE - HKSE Delayed price. Currency in HKD

Add to watchlist

0.580

+0.060

(+11.54%)

At close: 03:59PM HKT

All

PR Newswire
Broncus Medical (02216.HK) Announces Annual Results for 2023
On March 28, 2024, Broncus Medical (02216.HK) (the "Company" or "we" ) announced annual results for FY 2023.
PR Newswire
Broncus has announced the acquisition of the entire interest in Hangzhou Jingliang
Broncus(2216.HK) is pleased to announce that, on November 23 2023 Broncus Hangzhou (a whollyowned subsidiary of Broncus, as Transferee) has entered into the Equity Transfer Agreement with the shareholders of the Hangzhou Jingliang, to acquire 100% equity interest in it.
PR Newswire
Broncus Announced Long-Term Follow-Up Data on InterVapor, Showing Stable Long-Term Efficacy in Patients
During the 23th ERS International Congress on September 11, Broncus announced long-term follow-up data about Bronchoscopic Thermal Vapor Ablation (BTVA) treatment using InterVapor®, the Company's product for the treatment of Chronic Obstructive Pulmonary Disease ("COPD"). The data were published by Felix JF Herth, Full Professor of Medicine, University of Heidelberg.